Novasep Belgium
2000
FOUNDED
M&A
STATUS
91-100
EMPLOYEES
Buyout/LBO
LATEST DEAL TYPE
2
FINANCING ROUNDS
Description
Developer of bio-pharmaceutical products. The company develops recombinant proteins, subunit and live attenuated vaccines, monoclonal antibodies and viral vectors.
Website
Formerly Known As
Henogen
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Office
- Rue Clément Ader 16
- 6041 Gosselies
- Belgium
Novasep Belgium Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Novasep Belgium‘s full profile, request access.
Request full access to PitchBook